Open Journal of Endocrine and Metabolic Diseases

Open Journal of Endocrine and Metabolic Diseases

ISSN Print: 2165-7424
ISSN Online: 2165-7432
www.scirp.org/journal/ojemd
E-mail: ojemd@scirp.org
"The Ugly Side of Statins. Systemic Appraisal of the Contemporary Un-Known Unknowns"
written by Sherif Sultan, Niamh Hynes,
published by Open Journal of Endocrine and Metabolic Diseases, Vol.3 No.3, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] A biologia da crença
2022
[2] The Sicilian Secret Diet Plan
2022
[3] Evaluation of the Cholesterol-Lowering Mechanism of Enterococcus faecium Strain 132 and Lactobacillus paracasei Strain 201 in Hypercholesterolemia Rats
2021
[4] The new European guidelines for prevention of cardiovascular disease are misleading
2020
[5] A report on exercise resistance and suggestions for future research
2020
[6] Statins in Dentistry: Game Changer or Questionable Saga?
2019
[7] The Impact of Nutrition and Statins on Cardiovascular Diseases
2019
[8] Le Statine-Sono la vera ragione perché le linee guida ufficiali demonizzano ancora i grassi nonostante le prove?
2018
[9] The Dispute of Statins and Cholesterol: Can Statins Save Your Life by Abating the Risk of Heart Disease
2018
[10] Statin Drugs – The Real Reason Official Guidelines Still Demonize Fats Despite the Evidence?
Aletho News, 2018
[11] Estatinas:¿ La verdadera razón por la que las directrices oficiales todavía demonizan las grasas a pesar de la evidencia?
2018
[12] Statini-Pravi razlog zašto službene smjernice i dalje demoniziraju masnoće unatoč dokazima?
2018
[13] De biologie van de overtuiging: hoe je gedachten je leven bepalen
2017
[14] Mise en bouche talentueuse
Mercredi, 2017
[15] The Cholesterol Puzzle: The Hormone Connection
2017
[16] Cholesterol–High or Low? Good or Bad?
2017
[17] Statin Nation: The Ill-Founded War on Cholesterol, What Really Causes Heart Disease, and the Truth About the Most Overprescribed Drugs in the World
2017
[18] Obez Bireylerde Probiyotik Takviyesinin Ağırlık Kaybı ve Kan Lipit Düzeyleri Üzerindeki Etkisinin Değerlendirilmesi
2017
[19] OUP user menu
Eur Heart J, 2016
[20] Contribution of classical and emerging risk factors to coronary artery disease in Asian Indians
International journal of cardiology, 2016
[21] Omega-3 Fatty Acids: Keys to Nutritional Health
Springer International Publishing, 2016
[22] Omega-3 Polyunsaturated Fatty Acids and Hyperlipidaemias
Omega-3 Fatty Acids, 2016
[23] How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease
Expert review of clinical pharmacology, 2015
[24] Preliminary probiotic and technological characterization of Pediococcus pentosaceus strain KID7 and in vivo assessment of its cholesterol-lowering activity
Frontiers in microbiology, 2015
[25] Antihyperlipidaemic and Antioxidant Potential of Fermented Citrullus vulgaris Seeds (Thunb.) on Tyloxapol-induced Hyperlipidaemic Rats: A Comparison With Fluvastatin
Journal of Food Research, 2015
[26] COMPARATIVE DOCKING STUDY OF 'DUKUNG ANAK'PHYTONUTRIENT COMPOUNDS WITH ANTI-CHOLESTEROL PROPERTIES
Jurnal Teknologi, 2015
[27] Comparative docking study of “dukung anak” phytonutrient compounds with anti-cholesterol properties
2015
[28] Antihyperlipidaemic and Antioxidant Potential of Fermented Citrullus vulgaris Seeds (Thunb.) on Tyloxapol-induced Hyperlipidaemic Rats: A Comparison …
2015
[29] COMPARATIVE DOCKING STUDY OF ‘ DUKUNG ANAK’ PHYTONUTRIENT COMPOUNDS WITH ANTI-CHOLESTEROL PROPERTIES
2015
[30] OBEY X FUNKIE HOUSE 30TH ANNIVERSARY
2015
[31] Antihyperlipidaemic and Antioxidant Potential of Fermented Citrullus vulgaris Seeds (Thunb.) on Tyloxapol-induced Hyperlipidaemic Rats: A Comparison With …
2015
[32] Obesity a Significant Comorbid Concern With Statins. Are cholesterol-lowering drugs contributing to the obesity epidemic?
Natural Medicine Journal, 2014
[33] Financial system inquiry
2014
[34] Obesity a Significant Comorbid Concern With Statins
Natural Medicine Journal, 2014
[35] HMG-CoA 还原酶抑制剂-他汀类药物的作用及机制
中国现代药物应用, 2014
[36] 2013 AHA/ACC Cardiovascular Risk Reduction Guidelines-Drug Companies Win Again
2013
[37] Nutraceutica: moderata dislipidemia e patologia osteoarticolare. Utile un trattamento integrato?
2013
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top